Liddle's disease is an autosomal dominant form of human hypertension resulting from a basalactivation of amiloride-sensitive Na
+ channels (ENaC). This channel activation is produced by mutationsin the
- and/or
-carboxy-terminal cytoplasmic tails, in many cases causing a truncation of the last45-76 amino acids. In this study, we tested two hypotheses; first,
- and
-ENaC C-terminal truncationmutants (
C and
C), in combination with the wild-type
-ENaC subunit, reproduce the Liddle'sphenotype at the single channel level, i.e., an increase in open probability (
Po), and second, these C-terminalregions of
- and
-ENaC act as intrinsic blockers of this channel. Our results indicate that
CC-rENaC, incorporated into planar lipid bilayers, has a significantly higher single channel
Po compared tothe wild-type channel (0.85 vs 0.60, respectively), and that 30-mer synthetic peptides corresponding tothe C-terminal region of either
- or
-ENaC block the basal-activated channel in a concentration-dependentfashion. Moreover, there was a synergy between the peptides for channel inhibition when added together.We conclude that the increase in macroscopic Na
+ reabsorption that occurs in Liddle's disease is at leastin part due to an increase in single channel
Po and that the cytoplasmic tails of the
- and
-ENaC subunitsare important in the modulation of ENaC activity.